. Retraction to: 2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression. Carcinogenesis 2022 Jun 22. pii: 6610927. doi: 10.1093.
PMID: 35731146